Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers

Effects of Src-kinase inhibition in cancer-induced bone pain

(2016) Milena De Felice et al.   Molecular Pain

Emerging drugs for the treatment of bone metastasis

(2015) Francesco Pantano et al.   EXPERT OPINION ON EMERGING DRUGS

Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis

(2015) Yen-Nien Liu et al.   MOLECULAR AND CELLULAR BIOLOGY

Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?

(2014) Amir Sonnenblick et al.   CANCER TREATMENT REVIEWS

A complex of p190RhoGAP-A and anillin modulates RhoA-GTP and the cytokinetic furrow in human cells

(2014) A. Manukyan et al.   JOURNAL OF CELL SCIENCE

GD3 synthase regulates epithelial–mesenchymal transition and metastasis in breast cancer

(2014) T R Sarkar et al.   ONCOGENE

Manipulation Therapy Prior to Diagnosis Induced Primary Osteosarcoma Metastasis—From Clinical to Basic Research

(2014) Jir-You Wang et al.   PLoS One

Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2

(2014) Bethany N. Smith et al.   PLoS One

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

(2013) Dan R Robinson et al.   NATURE GENETICS

The current state of breast cancer classification

(2012) G. Viale   ANNALS OF ONCOLOGY

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement

(2012) S. Guiu et al.   ANNALS OF ONCOLOGY

c-Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis, but not in patients with visceral metastasis

(2012) LINGYUN ZHANG et al.   APMIS

Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy

(2011) M. Campone et al.   ANNALS OF ONCOLOGY

Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma

(2011) Y Su et al.   ONCOGENE

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

(2011) Dejuan Kong et al.   Cancers

Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors

(2010) John Araujo et al.   CANCER TREATMENT REVIEWS

ERα signaling through slug regulates E-cadherin and EMT

(2010) Y Ye et al.   ONCOGENE

The cytoskeleton and cancer

(2009) Alan Hall   CANCER AND METASTASIS REVIEWS

SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer

(2009) Fred Saad et al.   CANCER TREATMENT REVIEWS

Emerging therapeutic targets in breast cancer bone metastasis

(2009) April AN Rose et al.   Future Oncology

Targeting Src in breast cancer

(2008) R. S. Finn   ANNALS OF ONCOLOGY